05:26 PM EDT, 10/10/2025 (MT Newswires) -- David Raben, Chief Medical Officer, on October 09, 2025, sold 22,000 shares in Bicara Therapeutics ( BCAX ) for $405,900. Following the Form 4 filing with the SEC, Raben has control over a total of 35,497 common shares of the company, with 35,497 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2023658/000203467925000003/xslF345X05/wk-form4_1760131397.xml